Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126751831 | 12675183 | 1 | I | 20151107 | 20160818 | 20160823 | 20160823 | EXP | GB-MHRA-ADR 23599984 | GB-GLENMARK GENERICS (EUROPE) LTD.-2016GMK024025 | GLENMARK | 0.00 | Y | 0.00000 | 20160823 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126751831 | 12675183 | 1 | PS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | Oral | 4 MG, UNK | Y | 90926 | 4 | MG | |||||||
126751831 | 12675183 | 2 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | UNK, PRN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126751831 | 12675183 | 1 | Asthma |
126751831 | 12675183 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126751831 | 12675183 | OT |
126751831 | 12675183 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126751831 | 12675183 | Abnormal behaviour | |
126751831 | 12675183 | Aggression | |
126751831 | 12675183 | Screaming |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126751831 | 12675183 | 1 | 20151107 | 20160501 | 0 | |
126751831 | 12675183 | 2 | 201511 | 0 |